CSIMarket Company Name, Ticker, Suppliers, else..
 

Elite Pharmaceuticals Inc   (ELTP)

Elite Pharmaceuticals Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ELTP Sales vs. its Competitors Q4 2026


Comparing the current results to its competitors, Elite Pharmaceuticals Inc reported Revenue increase in the 4 quarter 2026 by 26.17 % year on year.
The sales growth was above Elite Pharmaceuticals Inc 's competitors' average revenue growth of 14.95 %, achieved in the same quarter.

• List of ELTP Competitors

With a net margin of 45.31 % Elite Pharmaceuticals Inc achieved higher profitability than its competitors.

• More on ELTP Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison

Elite Pharmaceuticals Inc Net Income in the 4 quarter 2026 grew year on year by 8.61%, faster than the Elite Pharmaceuticals Inc 's competitors average income growth of 5.96 %

<<  ELTP Stock Performance Comparisons


Elite Pharmaceuticals Inc 's Comment on Competition and Industry Peers


The company has paused development of the SequestOx™ product candidate due to the high cost of repeated bio-equivalence studies and an uncertain regulatory and competitive environment. There are no assurances regarding the conduct or success of future clinical trials, acceptance of future NDA resubmissions by the FDA, or future revenues or profits from the product.



  

Overall company Market Share Q4 2026
Due to strong revenue growth of 26.17 % in Overall company company increased its market share in this division.


<<  More on ELTP Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Elite Pharmaceuticals Inc




Nephros Inc
Share Performance



+1.90%
One Year
Nephros Inc
Profile

Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.

More about Nephros Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 47.562 mill. $ 21.686 mill. $ 1.736 mill.


Prf Technologies Ltd
Share Performance



-86.18%
One Year
Prf Technologies Ltd
Profile

Painreform Ltd operates under a business model focused on developing and commercializing innovative pharmaceutical solutions for pain management. Their approach involves creating novel drug formulations and delivery systems to improve the efficacy, safety, and patient experience in treating acute and chronic pain.

More about Prf Technologies Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.618 mill. $ 0.017 mill. $ -5.022 mill.


Rockwell Medical inc
Share Performance



+866.28%
This Year
Rockwell Medical inc
Profile

Rockwell Medical Inc operates with a business model focused on developing, manufacturing, and marketing innovative medical products and therapies. The company aims to address critical health challenges by providing proprietary dialysis solutions and iron maintenance therapies. Their approach includes collaborating with healthcare providers to improve patient outcomes and enhance the standards of care in chronic kidney disease management.

More about Rockwell Medical inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 32.757 mill. $ 67.550 mill. $ -5.404 mill.

Sources: Elite Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Elite Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.